Keya Medical is developing medical solutions using deep learning for cardiology, neurology, pulmonology, and other specialties. Keya Medical’s flagship product, DeepVessel FFR, is a software medical device that uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary computed tomography angiography (CTA) scans. In 2020, DeepVessel FFR became the first AI software medical device to receive regulatory clearance from the Chinese National Medical Products Administration. The company also received U.S. Food & Drug Administration 510(k) clearance for the intracranial hemorrhage triage software, CuraRad®-ICH. The company will continue to develop products using AI that support healthcare delivery organizations in providing better patient care.
About Keya Medical
Keya Medical is a medical technology manufacturer that develops AI applications that enable healthcare delivery organizations to provide better patient care. Since 2016, the company has combined advanced deep learning algorithms with other technologies to provide accurate diagnosis and treatment solutions to medical institutions around the world. Today, Keya Medical has partnered with over 200 healthcare systems around the world, and the company’s products are widely used in Chinese hospitals, coronary catheterization labs, and imaging centers. To learn more about Keya Medical, follow us on LinkedIn and Twitter.